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By
Mona A. Elshahat, Rania N. Sherief, Abd-Elhakim Z. Gabr,
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From
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ABSTRACT
Forty five male albino rats were
separated into nine groups (control,
2 model, and 6 treatment groups).
Rats in two model groups were given
intraperitoneal injection of 50% carbon tetrachloride (2ml/Kg twice
weekly for either 4 or 8 weeks). Rats
in treatment groups were given ccl4
for 8 weeks and also given losartan
(10mg/kg/day twice weekly), propolis
(100mg/kg/day twice weekly) or combined losartan and propolis via gastrogavage. The treatment started either simultaneously or after 4weeks
from beginning of ccl4 injection. Control group rats were given only olive
oil for the same period. At the assigned time, all rats were sacrificed.
Blood samples were taken for determination of serum indicators (SGOT,
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SGPT, ALP) and the livers were dissected out and prepared for histopathological study. There was a significant (P≥ 0.05) reduction in
fibrosis area and score and alphaSMA positivity in all sections of the
livers of animals that received treatment simultaneously with CCl4 for
8ws in comparison to ccl4 injection
alone for 8ws. There was also a significant reduction in the serum levels
of SGPT, SGOT and ALP, however,
these levels were still significantly
(P≥ 0.05) higher than control values.
When the treatment started after fibrosis has begun (after 4ws of ccl4
injection) the fibrosis process slowed
or even stopped with down regulation of active HSCs as evident by reduction of alpha-SMA positive stain.
However, the serum levels of enMANSOURA MEDICAL JOURNAL
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zymes were reduced to a lesser
degree. In all periods of treatment,
losartan was more effective in inhibition of HSCs and of fibrosis while
propolis was more effective in decreasing enzyme levels that may indicate more protection of hepatocytes. So, combined treatment gave
better reduction of both fibrosis and
enzyme levels. Reversal of already
present fibrosis was not evident in
this study.
Key words : liver fibrosis, losartan, propolis.

INTRODUCTION
Liver fibrosis refers to the accumulation of interstitial or ‘scar’ extracellular matrix (ECM) after either
acute or chronic liver injury (1). The
scars occur as the liver tries to repair
damaged tissue. The early deposition of fibrillar ECM (predominantly
collagen types I and III) in the subendothelial space of Disse is directly
responsible for the progressive reduction of liver function. Liver fibrosis
leads to cirrhosis, ultimately, endstage liver failure and increased risk
for hepatocellular carcinoma (2).
However, a concept of reversibility of
cirrhosis has been suggested by
many investigators over many dec-

ades (3). This has accelerated enthusiasm for developing antifibrotic therapies (4).
Reactive oxygen species (ROS)
have a rule in liver damage and progression of fibrosis by inducing
hepatic stellate cells (HSCs) proliferation and collagen synthesis (5).
Native propolis, which is a resinous
hive product collected by honeybees
from various plant sources, contains
many antioxidants. Its antioxidant
activity depends on the presence
of flavonoids (6; 7). The chemical
composition of propolis has a striking
variability depending on the site of
collection from different geographic
origin (8). As a result, recently almost
every publication on propolis biological activity includes some kind
of chemical characterization of the
bee glue used (9). The constituents
of the Egyptian propolis are phenolic
acid esters (72.7%), phenolic acids
(1.1%),
aliphatic
acids (2.4%),
dihydrochalcones (6.5%), Chalcones
(1.7%), flavanones (1.9%), flavones
(4.6%) and tetrahydrofuran derivatives (0.7%) (10; 11). Although several studies demonstrated a protective
effect of propolis on acute hepatotoxicity in rats induced by alcohol
and/or carbon tetrachloride (12; 13;
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14), and a decrease in chronic alco-

MATERIALS AND METHODS

hol induced hepatocellular fatty de-

45 adult male albino rats, with average body weight 200gm were used
in this study. They were housed in
stainless steel mesh cages at room
temperature. The animals were allowed free access to standard commercial diet and tap water ad libitum
with a 12h light–dark cycle throughout experimental periods. All procedures involving animals were carried
out in strict accordance with the international standards of animal care
guidelines and were approved by the
local ethical Experimental Animals
Committee.

generation (15). However, few studies focused on the effect of propolis
on prevention of liver fibrosis induced by chronic administration of
ccl4 (16) or dimethylnitrosamine in
rats (17).
A rule of rennin-angiotentin system in liver fibrosis has also been
suggested (18; 19; 20). Angiotensin II
(AngII) induces activation of HSCs in
vivo, a key event in liver fibrogenesis
(21). Angiotensin-converting enzyme

inhibitors and angiotensin II type 1
receptor (AT1R) blockers were tested in hepatic fibrosis induced by
CCl4 and a reduction in the mean fibrosis score and the progression of
hepatic fibrosis was observed (22;
23; 24; 25).

The aim of this study is to test the
effect of losartan (an antagonist of
AT1R) and propolis ( a potent antioxidant) on the prevention of liver fibrosis or the reversal of already present
liver fibrosis in CCl4 treated rats and
whether a combination of the two
could give better results. A combination of the two drugs was not tested
before.

Experimental drugs :
1- Carbon tetrachloride (CCl4):
Carbon tetrachloride solution was
purchased from El-Gomhoria Company, Egypt. Intraperitoneal injection
of 2ml/Kg sterile CCl4 dissolved in a
1:1 ratio with olive oil twice weekly
was done as previously described by
Iredale et al. (26).
2- Losartan (angiotensin-II receptor antagonist): Losartan
tablets
50mg from (Amriya Pharm. Indu.,
Egypt) were dissolved in tap water,
prepared as 1% solution and given
orally by gavage in a dose of 10mg/
kg/day, which is a clinically comparable dose for losartan (23).
MANSOURA MEDICAL JOURNAL
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3- Propolis (bee glue) powder:
Propolis powder was provided from
Faculty of Agriculture, Mansoura
University, Egypt. Propolis powder
was dissolved in warm tap water,
prepared as 10% solution and given
orally by gavage in a dose of 100mg/
kg/day as previously described by
Seo et al. (27).
Experimental design :
Male albino rats were randomly
divided into 5 groups:
• Control group (5 rats): received intra-peritoneal injection of
olive oil 0.2ml/100g twice weekly for
8 weeks. These rats were sacrificed
3 days after the last injection.
• Model groups (CCL4 injected)
(10 rats): received intra-peritoneal injection of CCl4 (2ml/kg dissolved in a
1:1 ratio of olive oil) twice weekly for
either 4 or 8 weeks (5 rats each).
These rats were sacrificed 3 days
(peak fibrosis time) after the last
CCl4 injection.
• Treated groups (30 rats): They
received intra-peritoneal injection of
CCl4 twice weekly for 8 weeks. Fifteen rats received the treatment of
losartan (5 rats), propolis (5 rats) or
combined losartan and propolis (5
rats) simultaneously with CCl4 injection for 8 weeks. Fifteen rats re-

ceived the treatment of losartan (5
rats), propolis (5 rats) or combined
losartan and propolis (5 rats) after 4
weeks from the bigenning of ccl4.
The rats were sacrificed 3 days after
the last CCl4 injection.
Tissue processing
At the assigned times, all rats
were anaesthetized with diethyl
ether; samples of blood were drawn
from the eye socket and collected in
polyethylene tubes. The livers were
rapidly removed and washed with
cold normal saline. A portion of the
liver was fixed in 10% phosphate
buffered formalin, processed by routine histological procedures, embedded in paraffin, cut in 6µm thick sections and mounted on slides. The
sections were stained with haematoxylin and eosin and sirius red that
specifically stains collagen.
Immunohistochemical staining for
α–SMA
Sections were subjected to deparaffinization, antigen retrieval and
endogenous peroxidase blocking
(3% hydrogen peroxide in methanol).
Mouse anti-human α-SMA monoclonal antibody, dilution 1:100 (DAKO)
which can detect rat ?-SMA was applied for 60 minutes at room temper-
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ature. Immunohistochemical staining
was performed by streptavidin-biotin
method using LSAB+ kit (DAKO)
with diaminobensidine as a chromogen and Meyer’s hematoxilin for
counterstaining. Negative control
was performed by leaving out the primary antibody during the staining
procedure.
Image analysis of the area occupied by collagen fibers
Quantitative assessment of liver
fibrosis was performed on sirius red
stained sections. The data were obtained using Leica Qwin 500 image
analyzer computer system (England). Using the measuring field
menu the area, area % and standard
measuring frame of a standard area
equal to 763882 µm2 were chosen
from the parameters. The percentage of the fibrosis area over the
whole observed field was assessed
to represent the degree of hepatic fibrosis. Several readings were obtained in each specimen (from 6
slides per animal) and at least ten
random fields were measured in
each slide (28).
The fibrosis grade
The grade of liver fibrosis in liver
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sections of all animals was estimated according to Ishak's modification
of HAI score (29).
Assessment of liver functions
The serum samples obtained by
centrifugation for 10 min at 3000 g at
4ºC were kept frozen at -80ºC until
assayed. The levels of serum glutamate-oxalate-transaminase (SGOT),
glutamate-pyruvate-transaminase
(SGPT) and alkaline phosphatase
(ALP) were assayed according to the
routine biochemical analysis system
using clinical test kits (Roche, Germany) spectrophotometrically (Cobas Mira Plus, Germany).
Statistical Analysis
The data are presented as means
± SD. The data obtained were subjected to statistical analysis using Ttest. The significance level was set
at P<0.05.

RESULTS
Liver parenchyma :
The histological appearance of
the liver in all rats of the control
group was formed of the classical
hepatic lobules. The lobules were
formed of cords of hepatocytes forming flat, anastmosing plates radiating
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from the central vein and separated
by hepatic sinusoids (figure 1a).
After four weeks of ccl4 injection,
most of the hepatocytes had pale cytoplasm with small vacuolations (microvesicles) while some of them had
large
vacuoles
(macrovesicles).
These changes appeared mostly in
the hepatocytes around central veins
and most of them had condensed
nuclei. Multiple areas of liver cells
destruction at the interface between
parenchyma and connective tissue
together with infilteration of the mononuclear inflammatory cells beyond
the connective tissue-parenchyma
interface had been detected. Mononuclear cellular infiltration was seen
in most of the portal areas. After 8ws
of ccl4 injection, there was increase
in the cytoplasmic vacuolation and a
marked distortion of the liver architecture. Obvious nodular fibrosis with
deposition of well-delineated fibrous
tissue septa had been detected (figure 1b).
In liver sections of the animals
that received losartan, propolis or
combined losartan and propolis either simultaneously with CCl4 injection for 8 ws or after 4ws from ccl4

adminstration, the liver parenchyma
showed mostly proper cord arrangement. However, multiple microvacuoles appeared in the hepatocytes
and increased in size near the portal
vein (figure 1c). The improvement in
histological picture was more apparent with longer period of treatment
as well as in the combined and propolis groups than in losartan group.
Liver fibrosis:
The hepatic lobules in control animals were demarcated by thin connective tissue formed of collagen fibers
containing
bile
ducts,
lymphatics, nerves and blood vessels. Fine collagen fibers appeared
to surround the central veins (figure
2a).
After four weeks of ccl4 injection
there was increase in the amount of
collagen fibers in the portal areas
and around the central veins. Thin
short septa could be seen extending
from most of the portal areas and
also the central veins into the surrounding parenchyma. Fibrous tissue
septa (bridging fibrosis) could be
seen linking the central veins together (centro-central) (figure 2b). After
8ws of ccl4 injection, there was
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marked increase in the amount of
collagen fibers in the portal tracts
and around the central veins. Thick
well developed septa could be seen
throughout the sections. These septa were extending from the portal areas and central veins connecting
them together. There was marked
distortion of the liver architecture
with pseudolobules formation (figure
2c).
In liver sections of animals that
received losartan, propolis or combined losartan and propolis simultaneously with CCl4 injection for 8ws,
there was minimal increase in the
amount of collagen fibers around
central veins and in the portal areas
as compared with the control. Few,
thin, short septa could be seen radiating from some portal tracts and
central veins into surrounding parenchyma with occasional porto-central
and centro-central septal bridging.
However, the septa were thicker in
propolis treated group and least in
the combined group of losartan and
propolis (figure 3).
Image analysis of sirius red
stained liver sections revealed that
the area occupied by collagen fibers
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was 3.08 ± 1.29%. The percentage
of area occupied by collagen fibers
and the grade of liver fibrosis according to Ishak score in the different
groups are given in figures 4 &5.
Although, there is significant (P≥
0.05) reduction in fibrosis area and
score in all treatment groups in
comparison to ccl4 injection for 8ws,
the groups that received treatment
during the last 4ws of ccl4 injection
did not show significant reduction
in comparison to ccl4 injection for
4ws i.e. in comparison to the starting
point. In the
propolis-treated
group, there was even a significant
increase in the grade of fibrosis
compared to the model group of ccl4
for 4ws.
Alpha-SMA immunohistochemistry:
In control animals, alpha-SMA
positive reaction was detected in the
muscle layer of the portal veins and
hepatic arteries within the portal
tracts. The terminal hepatic venules
revealed discontinous single layer of
α-SMA positive cells. Hepatocytes,
bile duct epithelial cells, endothelial
cells lining the sinusoids and Kupffer
cells were all negative for α-MA (figure 6a).
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There was increase in the number of α–SMA positive cells in the sinusoidal wall after 4ws of ccl4 injection. Alpha-SMA positive stain could
be detected around the central veins
and in the thin fibrous band (figure
6b). At 8ws, alpha-SMA positive
cells were distributed in the thick fibrous tissue septa (figure 6c).
In the animals that received treatment simultaneously with CCl4 for
8ws, few α–SMA positive cells appeared only in the perisinusoidal
spaces mostly in the pericentral areas. However, α–SMA positive stain
was also observed along the thin fibrous septa in propolis treated group
(figure 7a, d, j). When the treatment
was confined to the last 4ws of CCl4
injection period, more alpha-SMA
positive cells were observed. AlphaSMA expressing cells were seen in
the portal areas, perivenular areas
and adjacent perisinusoidal spaces.
Alpha-SMA positive cells also appeared along the thin fibrous tissue
septa (figure 7b, c, e, f, h and g).

The immunoreactive cells were more
numerous in the propolis treated
groups than losartan groups which in
turn were more than the combined
groups.
Serum enzymes :
The serum levels of glutamatepyruvate-transaminase (SGPT), glutamate-oxalate-transaminase(SGOT)
and alkaline phosphatase (ALP)
were all within normal range in all
rats of the control group (figures 8a,
b and c). Marked elevation of enzyme levels followed administration
of ccl4 for 4 or 8ws. The serum enzymes levels were lowered significantly (P≥ 0.05) in all treatment
groups as compared to ccl4 injection
for 8ws but still significantly (P≥
0.05) higher than control. Starting
the treatment simultaneously with
ccl4 was more effective in lowering
enzyme levels than starting it after 4
weeks from ccl4 injection. Propolis
and combined treatment gave better
results than losartan (figures 8a, b
and c).
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Figure 1: Photomicrographs of liver sections from albino rats: 1a: control group
showing hepatic lobules formed of cords of hepatocytes radiating from
the central vein and separated by hepatic sinusoids. 1b: ccl4 injected
group for 8ws; marked cytoplasmic vacuolations (arrows) and necrotic
cells (arrow heads) are observed. Obvious nodular fibrosis with deposition of well-delineated fibrous tissue septa (*) can be detected. 1c: combined losartan and propolis simultaneously administered with CCl4 injection for 8 ws, the liver parenchyma showed mostly proper cord
arrangement. However, microvacuoles appeare in the hepatocytes and
increase in size near the portal vein (arrows).
(H&E X 40)

Figure 2: Photomicrographs of liver sections from albino rats. 2a: control group
showing normal distribution of collagen fibers around the central vein (v)
and in the portal tract (p). 2b: liver section of rat received CCl4 injection
for 4ws showing increase in the amount of collagen fibers as compared
to control. Thin septa could be seen extending from the central veins into
the surrounding parenchyma. Some of these septa are linking the central
veins together and to the portal (arrows). 2c: CCl4 injection for 8ws
showing thick well-developed septa (arrows) throughout the section with
pseudolobules (Lo) formation. (Sirius red X 40)
MANSOURA MEDICAL JOURNAL
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Figure 3: Photomicrographs of liver sections from albino rats of losartan (3a, 3d), propolis (3b, 3f) and combined losartan and propolis (3c, 3g) treated groups: minimal increase in the amount of collagen fibers (red) around central veins and in the portal areas is observed in simultaneous treatment with CCl4 injection for 8ws (3a, 3b, 3c). Few thin short septa are seen radiating into
surrounding parenchyma (arrows). The septa are thicker in propolis treated group (3b). Treatment after four weeks (3d, 3f, 3g) from the beginning of CCl4 injection shows increase in the
amount of fibrosis with occasional porto-central and centro-central bridging (arrows). Relatively thick septa extending into the surrounding parenchyma with multiple bridging and pseudolobules (Lo) formation are observed in propolis treated sections (3f).
(Sirius red X 40).
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Figure 4: Histogram of the percentage of area occupied by collagen fibers in Sirius
red stained sections. For all treatment groups there is significant (* P≥
0.05) decrease in percentage of area occupied by collagen fibers in comparison to ccl4 injection for 8ws. However, the percentage area is still
significantly (# P≥ 0.05) higher relative to control. Groups that received
treatment for the last 4ws of ccl4 injection are comparable to ccl4 injection for 4ws. Abbreviations: Control (C); Carbon tetrachloride (CCl4); Losartan (L); Propolis (P); Losartan plus propolis (L&P).

Figure 5: Histogram of the grade of liver fibrosis according to Ishak score. For all
treatment groups there is significant (* P≥ 0.05) decrease in grade of liver fibrosis in comparison to ccl4 injection for 8ws. But the grades are still
significantly (# P≥ 0.05) higher relative to control. Groups that received
treatment for the last 4ws of ccl4 injection are comparable to ccl4
injection for 4ws except for propolis-treated group which is significantly
higher.
MANSOURA MEDICAL JOURNAL
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Figure 6: Photomicrographs of liver sections from albino rats. 6a: control group
showing the α-SMA positive cells in the muscle layer of vessels in portal
tract (arrows). 6b: liver section of rats received CCl4 injection for 4ws,
showing α-SMA positive cells in the fibrous band (arrows). 6c: CCl4 injection for 8ws, showing more α SMA positive cells distributed in the
thick fibrous tissue septa (arrows).
(Immunohistochemistry for α- SMA

X 100).
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Figure 7: Photomicrographs of liver sections from albino rats of losartan (7a, 7d), propolis (7b, 7f) and combined losartan and propolis (7c, 7g) treated groups: few α-SMA positive cells in the perisinusoidal wall within the liver parenchyma (arrows) are observed in simultaneous treatment with
CCl4 injection for 8ws (7a, 7b, 7c). Treatment after four weeks (7d, 7f, 7g) from the beginning of
CCl4 injection shows increase in the α-SMA positive cells in the sinusoidal wall around the central
veins and along the thin fibrous tissue septa (arrows). α-SMA immunoreactivity is more in propolis
treated groups (7b, 7f).
(immunohistochemistry for α-SMA X100)
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Figure 8: Histogram of the serum enzyme levels of liver markers: serum glutamicpyruvic transaminase (SGPT); serum glutamic oxaloacetic transaminase
(SGOT) and alkaline phosphatase (ALP). Note the marked elevation of enzyme levels that followed administration of ccl4 for 4 or 8ws. The serum
enzymes levels were lowered significantly (* P≥ 0.05) in all treatment
groups as compared to ccl4 injection for 8ws but still significantly (# P≥
0.05) higher than control. Starting the treatment simultaneously with ccl4
was more effective in lowering enzyme levels than starting it after 4 weeks
from ccl4 injection. Abbreviations: Control (C); Carbon tetrachloride
(CCl4); Losartan (L); Propolis (P); Losartan plus propolis (L&P); significant
elevation in comparison to ccl4 injection for 4ws ($).
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DISCUSSION
Hepatic fibrosis is strongly associated with oxidative stress, increased transforming growth factor
beta, hepatocyte death, and chronic
inflammation (30). Chronic damage
to the liver in conjunction with the accumulation of ECM proteins results
in fibrosis, which is a characteristic
of most types of chronic liver diseases (2). Activated hepatic stellate cells
(HSCs) are the main ECM-producing
cells in the injured liver. They migrate and accumulate at the sites of
tissue
repair,
secreting
large
amounts of ECM and regulating
ECM degradation (31). HSCs are
supposed to be one of the most important cell targets of the pathogenetic action of angiotensin II for liver
fibrosis and portal hypertension by
accelerating the activation process
of these cells (21). Key components
of angiotensin system are locally expressed in normal liver tissue and
upregulated in chronically injured livers (19) and activated HSCs de
novo generate angiotensin II (20).
Because the angiotensin II type 1 receptors (AT1R) antagonists have
been used clinically for cardiovascular disorders, and have been confirmed as safe and without major
side effects, the study of the effects

of AT1R antagonists on liver fibrosis
opens new possibilities for the prevention and treatment of hepatic fibrosis (32; 33). In the present study,
losartan (an AT1R antagonist) was
given to animals simultaneously with
ccl4 for 8 weeks or after 4 weeks
from start of ccl4 treatment. AlphaSMA positive stain was markedly diminished in all sections of the livers
of animals that received losartan
treatment simultaneously with CCl4
for 8ws with a significant reduction in
fibrosis area and score in comparison to ccl4 injection alone for 8ws.
When the treatment started after fibrosis has begun (after 4ws) the fibrosis process slowed or even
stopped with down regulation of active HSCs as evident by reduction of
alpha-SMA positive stain. The active
HSCs were more than control as evident by more alpha-SMA positive
stain but significantly less than ccl4
injection alone for 8 weeks. The fibrosis area and score were also significantly decreased. Previous studies also demonstrated the inhibiting
effect of losartan on liver fibrosis (32;
24; 25). Losartan has also been tested in some clinical trials as Sookoian et al. (34) and Yokohama et al.
(35) who evaluated the safety and efficacy of chronic administration of lo-
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sartan on hepatic fibrosis in chronic
hepatitis C and non-alcholic steatohepatitis and reported that losartan
significantly decreased the fibrosis
stage with remarkable decrease in
activated HSCs. Angiotensin II type
1 receptor antagonist induces its effect on HSCs and in turn on liver fibrosis by either of two mechanisms
of action: first, inhibits activated
HSCs by blocking AT1R expressed
on the surface of HSCs; second, it
suppresses the activation of HSCs
as a result of the decrease in transforming growth factor beta (TGF-β1)
(36). TGF-β1 activates directly HSCs,
stimulates synthesis of multiple
ECMs, inhibits ECM degradation by
stimulating the production of tissue
inhibitors of metalloproteases and increasing its own synthesis (30).
Oxidative stress is associated
with liver fibrosis and with HSCs activation in vivo. Hepatocytes undergoing oxidative stress release factors
which are fibrogenic for HSCs (37).
Many antioxidants such as vitamin
E, silymarin, phosphatidylcholine,
and S-adenosyl-L-methionine have
been shown to inhibit HSC activation, protect hepatocytes from undergoing apoptosis, and attenuate experimental liver fibrosis (31). Propolis
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has proved to possess strong antioxidant and scavenging abilities and
significantly decreased lipid peroxidation processes (LPO) in plasma,
liver, lungs, and brain of mice (38). It
inhibited oxidative stress induced by
CCl4 when the extract was added to
the isolated hepatocytes in vitro (39).
Its antioxidant activity depends on
the presence of flavonoids (6; 7).
Many flavonoids were tested in liver
fibrosis and proved to be effective in
reducing fibrosis (40; 41). A protective effect of propolis on hepatic fibrosis induced by either dimethylnitrosamine or ccl4 in rats was shown
by Gergerlioglu et al., (17) and Bhadauria (16). In the present study, propolis protected the liver parenchyma
and significantly reduced the fibrosis
area and score and alpha-SMA positive stain when introduced simultaneously with ccl4, however, its effect
on fibrosis was less than that of losartan and combined treatment.
Starting propolis treatment after 4ws
from ccl4 injection did not improve
the picture than the starting point.
In this study, the markers of liver
injury SGPT (ALT), SGOT (AST) and
ALP were significantly reduced in the
treated groups as compared to ccl4
injection for 8ws, however, these levMANSOURA MEDICAL JOURNAL
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els were still significantly higher than
control values. Starting the treatment
after 4 weeks of ccl4 injection reduced the serum levels of enzymes
to a lesser degree. The reduction in
the serum levels of the enzymes was
more prominent with propolis and
combined treatment than with losartan alone. Previous studies also
showed that prophylactic treatment
with propolis had a significant effect
on reduction of the elevated ALT,
AST and lipid peroxides and elevation of the reduced Glutathione
(GSH) in blood and liver after acute
hepatotoxicity (12; 13; 14) and chronic
liver injury (16; 17).
In this study, in all periods of
treatment, losartan was more effective in inhibition of HSCs and of fibrosis while propolis was more effective
in decreasing enzyme levels that
may indicate more protection of hepatocytes. Combined treatment of the
two drugs that have different mechanism of action gave better reduction
of both fibrosis and enzyme levels.
Reversal of liver fibrosis by treatment with losartan and propolis was
not evident in this study.
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